Remedium raises $10m for adjustable gene therapy
Lilly joins Series A backing a platform designed to turn adipocytes into long-term, adjustable producers of therapeutic proteins. Remedium B
The week in healthy ageing
Longevity news
A curated digest of the latest longevity and healthy-ageing research and news, updated weekly. Headlines and a short read, with a link to the original source.
Beyond protein: what really matters for healthy aging
As protein becomes the latest nutrition obsession, experts unpack what actually keeps us healthy as we age, from movement to food to habits.
A Review of Approaches to Rejuvenate Aging Hematopoietic Stem Cells
Technically, even very small effects can be classed as rejuvenation if they move the right markers, if they in some way reduce the burden of
Altered Bile Acid Metabolism is Related to Gut Microbiome Aging
Researchers here discuss a bidirectional relationship between age-related alterations in bile acid metabolism, centered in the liver, and ch
Greenstone receives NIH R61 grant for cardiac fibrosis
Greenstone Biosciences has received a Catalyze R61 award from the National Heart, Lung, and Blood Institute, part of the National Institutes
Acquisition adds RayThera immunology assets to Biogen pipeline
Biogen completed the acquisition of RayThera Inc., a privately held biotechnology company focused on discovering and developing small-molecu
Alterity Therapeutics to present MSA drug trial progress at Canaccord conference
Alterity Therapeutics will present at the 46th Annual Canaccord Genuity Growth Conference, with CEO David Stamler scheduled to speak on Tues
Tarsus buys Alkeus for $450m to expand into rare eye disease treatments
Tarsus Pharmaceuticals has entered a definitive agreement to acquire Alkeus Pharmaceuticals, bringing gildeuretinol (ALK-001), an investigat
Get this in your inbox
The week's longevity news, curated, once a week. No noise.